Carregant...
Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae
Bartonella henselae can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infections, in this study, w...
Guardat en:
| Publicat a: | Antibiotics (Basel) |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628006/ https://ncbi.nlm.nih.gov/pubmed/31035691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics8020050 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|